Navigation Links
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
Date:5/26/2008

argement of the liver and spleen. In some cases, central nervous system involvement leads to progressive neurologic decline.

Shire Human Genetic Therapies is actively tracking health data among individuals affected by Hunter syndrome as part of the company's long-term outcome survey, called the Hunter Outcome Survey (HOS). HOS is designed to support the gathering, analysis, reporting and sharing of data from around the world about Hunter syndrome. Shire believes that the inclusion of all people affected by Hunter syndrome, whether on therapy or not, and the analysis and dissemination of this information will allow for further understanding of Hunter syndrome and disease education on a global scale.

Shire Limited

Shire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on attention deficit and hyperactivity disorder (ADHD), human genetic therapies (HGT), gastrointestinal (GI) and renal diseases. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire's in-licensing, merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the US or Europe. Shire believes that a carefully selected portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.

For further information on Shire, please visit the Company's website: http://www.shire.com.

"SAFE HARBOR" STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

Statements included herein that are not historical facts are forward-looking statements. Such forward-looking statements involve a number of risks and uncertainties and are subject to change at any time. In the event such risks or uncertaint
'/>"/>

SOURCE Shire Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
2. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
3. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
4. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
5. Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program
6. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
7. BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
8. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
9. QuatRx Pharmaceuticals Announces Presentation of Further Data from Ophena(TM) (Ospemifene) Phase 3 Study for Treatment of Symptoms of Vulvovaginal Atrophy
10. Alba Therapeutics Announces the Presentation of Results of a Phase IIa Clinical Trial for Larazotide Acetate for the Treatment of Celiac Disease at the Digestive Disease Week Conference
11. PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... The spinal column is one of the most delicate and ... from the brain through the column control many key functions ... here can be life altering, and leave the victim in ... body. Though back injury and disease can have an intensely ... available to make things better than ever before. Laser ...
(Date:8/21/2014)... /CNW/ - Eisai Limited is pleased to support the Canadian ... book available in Canada . The comic ... educate children and their parents about epilepsy, the most common ... than 300,000 Canadians. Eisai is guided by a corporate philosophy ... the patient is central – there was a need within ...
(Date:8/21/2014)... Mass. , Aug. 21, 2014  Decision ... COPD,  physicians in Brazil ... follow clinical guidelines and commonly prescribe long-acting beta-agonist ... although they do so within current severe cost/coverage ... (FDCs) that are expected to launch in these ...
Breaking Medicine Technology:Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3
... , PALM CITY, Fla. , Jan. ... CTYX.PK) is pleased to announce its association with the commencement ... agreement provides for the promotion of MedFlash® through The Orlando ... Orlando, Florida,s Walgreens stores.  In store promotional displays ...
... , NEW YORK , ... biopharmaceutical company developing novel therapeutics for chronic fibrotic and metabolic ... Preferred Series B financing by its majority shareholder Genextra ... CEO commented, "This financing is recognition of the success we ...
Cached Medicine Technology:Connectyx Announces MedFlash(R) 'Sixth Man Fan Promotion' in Conjunction With Walgreens and The Orlando Magic 2Connectyx Announces MedFlash(R) 'Sixth Man Fan Promotion' in Conjunction With Walgreens and The Orlando Magic 3Connectyx Announces MedFlash(R) 'Sixth Man Fan Promotion' in Conjunction With Walgreens and The Orlando Magic 4Intercept Pharmaceuticals Raises $25 Million Series B Financing 2Intercept Pharmaceuticals Raises $25 Million Series B Financing 3
(Date:8/21/2014)... August 21, 2014 Transvaginal mesh ... Inc. continue to move forward in the federal ... District of West Virginia, Bernstein Liebhard LLP reports. ... 14th, the Court has established new stipulated evidence ... handling, division, storage and preservation. (In re C.R. ...
(Date:8/21/2014)... physicians in rural communities do not routinely screen ... Penn State medical and public health researchers. Rural ... limited resources if they seek help., "Rural health ... said Jennifer S. McCall-Hosenfeld, a primary care physician ... sciences, Penn State College of Medicine. "However, in ...
(Date:8/21/2014)... The world wound care market is expected ... reach USD 18.3 billion by 2019, posting a CAGR ... such growth include governments’ contribution to the development of ... surging ageing population. However, the growth could be restrained ... North America leads the global wound care market, with ...
(Date:8/21/2014)... NJ (PRWEB) August 21, 2014 Lauren Collura, ... of the 2014 “Back to the Boardwalk” Facebook sweepstakes. Lauren, ... at a beautiful four-bedroom beachfront house in Lavallette beginning this ... “Back to the Boardwalk” sweepstakes. Last year, Horizon Blue Cross ... shore communities after Superstorm Sandy and decided to make it ...
(Date:8/21/2014)... In a new review of seafood safety, Consumer Reports ... to concerns about mercury exposure. "We,re particularly concerned ... as the most commonly eaten seafood in the United ... Jean Halloran, director of food policy initiatives for Consumers ... a news release from the group. While pregnant ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward in Federal C.R. Bard Litigation with Issuance of New Pretrial Order, Bernstein Liebhard LLP Reports 3Health News:Primary care physicians can be critical resource for abused women in rural areas 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 2Health News:Global Wound Care Market to Post 3.2% CAGR Through 2019, Says MarketsandMarkets in Its New Report Published at MarketPublishers.com 3Health News:Consumer Reports Advises Pregnant Women to Avoid Tuna 2
... Art Slutsky, vice-president of research at St. Michael,s Hospital, ... Assembly on Critical Care Lifetime Achievement Award. , The ... critical care academic clinician for contributions to research, patient ... was the keynote speaker at the annual Critical Care ...
... HealthDay Reporter , TUESDAY, May 22 (HealthDay News) -- ... risk of prostate cancer, a preliminary study suggests. ... the prostate were more likely to have cancer than were ... should be aware that they may benefit from being screened ...
... SAN FRANCISCO New research presented at the ATS 2012 ... proportion of children with asthma failing Step 4 or ... (SAFS). "SAFS is a newly described sub-phenotype of ... are unknown," said Alfin Vicencio, MD, chief of pediatric ...
... 2012, SAN FRANCISCO Vitamin C supplementation in pregnant women ... function in their newborns, according to a new study. ... the lung development of the developing baby," said Cindy ... & Science University Doernbecher Children,s Hospital. "We found that ...
... Israel Deaconess Medical Center, in Boston, and the Massachusetts ... ill patients were more likely to die if they ... were admitted to the intensive care unit (ICU)., The ... records of 10,568 patients to look at in-hospital mortality ...
... AT A GLANCE, Diabetic foot complications are the ... of all patients who have a foot amputated die ... proper care of diabetic foot infections, suggest new guidelines ... A multi-disciplinary team including infectious diseases specialists, podiatrists, ...
Cached Medicine News:Health News:Do Bald Men Face Higher Risk of Prostate Cancer? 2Health News:Do Bald Men Face Higher Risk of Prostate Cancer? 3Health News:Children failing asthma therapy may have severe asthma with fungal sensitization 2Health News:Vitamin C improves pulmonary function in newborns of pregnant smoking women 2Health News:Antidepressant use associated with increased mortality among critically ill patients? 2Health News:Correct treatment of common diabetic foot infections can reduce amputations 2Health News:Correct treatment of common diabetic foot infections can reduce amputations 3
The Stat-Let lines of disposable lancets are all designed with the goals of providing a safe and easy to achieve capillary blood sampling. All of our lancets can be used by most current models of lan...
... Maximize blood flow while minimizing ... stick with the safety-engineered BD ... Microtainer Genie Lancet offers a ... needles for capillary blood collection ...
Lancets are the fine needles used with a lancing device to draw a blood sample for glucose testing. To make testing less painful, we developed lancets with extra-thin tips....
The DiaSTAT™ is an automated liquid chromatography system designed for the rapid and automated analysis of hemoglobin A1C. Ideal for low and ,medium volume testing environments....
Medicine Products: